Order Article Reprints

Marco C, Simó M, Alemany M, Casasnovas C, Domínguez R, Vilariño N, Calvo M, Martín-Liberal J, Brenes J, Sabater-Riera J, et al. Myasthenia Gravis Induced by Immune Checkpoint Inhibitors: An Emerging Neurotoxicity in Neuro-Oncology Practice: Case Series. Journal of Clinical Medicine. 2023; 12(1):130. https://doi.org/10.3390/jcm12010130

Marco, Carla, Marta Simó, Montse Alemany, Carlos Casasnovas, Raúl Domínguez, Noelia Vilariño, Mariona Calvo, Juan Martín-Liberal, Jesús Brenes, Joan Sabater-Riera, and et al. 2023. "Myasthenia Gravis Induced by Immune Checkpoint Inhibitors: An Emerging Neurotoxicity in Neuro-Oncology Practice: Case Series" Journal of Clinical Medicine 12, no. 1: 130. https://doi.org/10.3390/jcm12010130

Marco, C., Simó, M., Alemany, M., Casasnovas, C., Domínguez, R., Vilariño, N., Calvo, M., Martín-Liberal, J., Brenes, J., Sabater-Riera, J., Bruna, J., & Velasco, R. (2023). Myasthenia Gravis Induced by Immune Checkpoint Inhibitors: An Emerging Neurotoxicity in Neuro-Oncology Practice: Case Series. Journal of Clinical Medicine, 12(1), 130. https://doi.org/10.3390/jcm12010130